Skip to main content
VERICI DX PLC logo

VERICI DX PLC — Investor Relations & Filings

Ticker · VRCI ISIN · GB00BM8HZD43 LEI · 213800FI5WE4FVQ3G645 IL Real estate activities
Open in API
Filings indexed 195 across all filing types
Latest filing 2026-06-05 Capital/Financing Update
Country GB United Kingdom
Listing IL VRCI

About VERICI DX PLC

https://www.vericidx.com/

Verici Dx is an immuno-diagnostics company developing and commercializing a suite of proprietary tests for the kidney transplant market. The company's platform utilizes artificial intelligence-assisted transcriptomic analysis of RNA signatures to provide data-driven insights to clinicians. These tests are designed to decipher the body's immune response and other biological signals, enabling personalized risk assessment for organ injury, rejection, and graft failure. The goal is to assist clinicians in medical management throughout the transplant process, from pre-transplant to late-stage care, ultimately aiming to improve patient outcomes and long-term graft survival.

Recent filings

Filing Released Lang Actions
Result of Placing & raising gross proceeds c£2.5m
Capital/Financing Update Classification · 91% confidence The document is a Regulatory News Service (RNS) announcement by Verici Dx plc dated 05 June 2026, detailing the successful placing of new shares to raise gross proceeds of approximately £2.5 million, terms of the fundraising, admission of new shares, related party participation, and voting rights. It is an update on a capital raise transaction, fitting the definition of a Capital/Financing Update filing (CAP).
2026-06-05 English
Proposed Fundraising via Placing
Capital/Financing Update Classification · 90% confidence The document is a Regulatory News Service (RNS) announcement by Verici Dx PLC detailing a proposed equity fundraising via an institutional placing and retail offer, with full terms, use of proceeds, timetable, and associated broker details. It is clearly an update on the company’s capital‐raising activity rather than a report of financial results or a standalone regulatory filing. This matches the definition of a Capital/Financing Update (CAP).
2026-06-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 95% confidence The document is an RNS release titled “TR-1: Standard form for notification of major holdings,” detailing UBS Group AG’s voting rights in Verici Dx PLC falling below the 5% threshold. This is a regulatory notification of significant shareholding changes, matching the Major Shareholding Notification category.
2026-06-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 93% confidence The document is an FCA TR-1 standard form for notification of major holdings filed via the London Stock Exchange’s RNS service. It records UBS group’s acquisition/disposal and threshold crossing of Verici Dx PLC shares, which is a Major Shareholding Notification. This exactly matches category 20 (Code: MRQ).
2026-06-02 English
Study validating economic advantages of PTRA test
Regulatory Filings Classification · 91% confidence The document is a press release published via the London Stock Exchange’s RNS system announcing the publication of a health economics study. It contains no financial statements, no regulatory certifications, no meeting or voting details, and no indication of a specific report attachment or Excel supplement. It is a general corporate/regulatory announcement and does not fit specialized categories such as earnings release, AGM materials, interim report, or M&A filing. Therefore, it falls under the generic “Regulatory Filings” category (RNS).
2026-06-02 English
AMA grants additional CPT® Code for ProtegaTM
Regulatory Filings Classification · 10% confidence The document is a Regulatory News Service (RNS) announcement by Verici Dx plc about receiving an AMA CPT code for their Protega test. It is not a financial report (e.g., Annual Report, Interim Report), earnings release, management change, or any specific corporate action like M&A or share issues. It is a general regulatory/market announcement distributed via the London Stock Exchange’s RNS service, fitting the Regulatory Filings (RNS) category.
2026-06-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.